Files
Download Full Text (569 KB)
Document Type
Poster
Description
GLP-1 therapies show promise in managing type 2 diabetes and obesity in adolescents. This review explores the efficacy, safety, and variations in treatment outcomes. GLP-1 therapies (liraglutide, dulaglutide, exenatide) effectively reduce HbA1c levels. Weight reduction is a positive outcome crucial for type 2 diabetes and obesity management. Safety concerns and gastrointestinal effects emphasize the need for monitoring during GLP-1 therapy. Insights from studies on Lixisenatide offer valuable information for healthcare providers. There is consensus on general effectiveness, but debates on specific outcomes and long-term effects persist. Case-based investigations suggest potential variations in treatment responses, requiring further exploration. Bridging the gap between research and application. Empowering clinicians to make informed decisions, considering individual patient needs for enhanced quality of care.
Department
Physician Assistant Studies
Degree Name
Master of Physician Assistant Studies (MPAS)
Date of Work
2024
First Advisor
Metzger, Jay
Second Advisor
Kauffman, Russell
Publication Date
Spring 2024
Disciplines
Medicine and Health Sciences
Recommended Citation
Mahrer, Cayla, "The Efficacy of GLP-1 Agonists in Pediatrics with Type 2 Diabetes and Obesity" (2024). Physician Assistant Scholarly Project Posters. 284.
https://commons.und.edu/pas-grad-posters/284